Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 205 clinical trials
A Study to Learn More About How Acarbose and Metformin Work When Taken Together and How Safe They Are in Indian Patients Who Were Recently Diagnosed With Type 2 Diabetes (T2D) (START-AM)

The study drug, fixed dose combination of acarbose and metformin, have already been approved to take together as a treatment for type 2 diabetes (T2D). Sometimes, researchers continue studying a

hemoglobin a1c
acarbose
sugars
metformin
  • 0 views
  • 30 Jun, 2022
  • 1 location
Efficacy of Chemopreventive Agents on Disease-free and Overall Survival in Patients With Pancreatic Ductal Adenocarcinoma: The CAOS Study (CAOS)

The evidence on the value of aspirin, statins, metformin, beta-blocking ACE inhibitors agents as chemopreventive agents in patients with pancreatic ductal adenocarcinoma is limited. The

breast ductal carcinoma
immunostimulant
chemoradiotherapy
pancreatic ductal adenocarcinoma
adenocarcinoma
  • 0 views
  • 25 Feb, 2022
  • 1 location
Cancer in Patients on Dapagliflozin and Other Antidiabetic Treatment

females who are new users of antidiabetic drugs (ADs) in classes other than sodium-glucose cotransporter 2 (SGLT2) inhibitors, insulin monotherapy, metformin monotherapy, or sulfonylurea monotherapy and

cancer
bladder cancer
bladder tumor
metformin
  • 3 views
  • 04 Jun, 2022
  • 4 locations
Gliflozins and Cardiovascular Risk Factors in Type 2 Diabetes (GIOIA) (GIOIA)

of vascular, myocardial and renal damage, in patients with type 2 diabetes not well controlled with metformin and/or basal insulin. The changes of the interest outcomes are compared with those

sglt2
canagliflozin
hemoglobin a1c
dapagliflozin
sglt2 inhibitor
  • 0 views
  • 03 Feb, 2022
  • 1 location
Cognitive Protective Effect of Newer Antidiabetic Drugs

The proposed study aims to: Explore the cognitive protective effects of SGLT2 inhibitors and DPP-4 inhibitors in patients attending diabetic clinics in Alexandria Examine the possible relationship of such effects with the systemic inflammatory and metabolic status in these patients Undertake a network analysis to elucidate the potential pathways linking …

antidiabetic agents
Accepts healthy volunteers
sitagliptin
  • 0 views
  • 14 May, 2022
  • 1 location
Comparison of Type 2 Diabetes Pharmacotherapy Regimens

This study is designed to help patients with type 2 diabetes and their clinicians: (a) identify which glucose lowering medications have the most favorable effects on heart health and other patient-important outcomes, (b) inform the timing of medication initiation, and (c) identify whether medication benefits apply equally to all adults …

diabetes
exenatide
liraglutide
glucagon
glimepiride
  • 0 views
  • 19 Oct, 2021
  • 5 locations
BESTMED: Observational Evaluation of Second Line Therapy Medications in Diabetes

An observational study of electronic patient data to compare diabetes medications and to determine which ones offer the best balance of risks and benefits.

  • 0 views
  • 29 Dec, 2021
  • 5 locations
Metformin Usage Index and Vitamin B12 Status in Egyptian Type 2 Diabetic Patients

, effective management of the disease is crucial. The American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) recommend metformin as the first therapeutic

hemoglobin a1c
low density lipoprotein
glycosylated hemoglobin
fasting blood glucose
type 2 diabetes mellitus
  • 0 views
  • 11 Apr, 2022
  • 1 location
The Effect of In-utero Exposure to Metformin in 5-11 Year Old Offspring of Mothers in the MiTy Trial (MiTy Tykes)

The incidence of diabetes in pregnancy is rising, with rates of 1 in 7 pregnancies globally. Metformin is used for type 2 diabetes (T2DM) outside of pregnancy and is now increasingly prescribed

diabetes
insulin resistance
adipokine
metabolic syndrome
childhood obesity
  • 0 views
  • 03 Jun, 2022
  • 1 location
The Effect of Metformin and DPP4 Inhibitors on Cognition and Cardiovascular Protection in Type 2 Diabetic Patients

The Impact of Metformin and Dipeptidyl Peptidase- 4 Inhibitors on Cognitive Function and cardiovascular protection in Type 2 Diabetic Patients

  • 0 views
  • 30 Jun, 2022